Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients

NCT00436592 is registered in ClinicalTrials.gov with CoAxia as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00436592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
Lead sponsor
CoAxia
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2007
Completion date
January 31, 2009
Enrollment
26 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident